[Experience of Elcitonin treatment in metastatic bony pain of urological tumors].
Fourteen cases of urogenital tumors (9 prostatic carcinomas, 4 renal cell carcinomas and 1 bladder carcinoma) which had bone metastases were treated with eel-calcitonin, Elcitonin injections for relief of bony pain. Forty mgs. of Elcitonin was injected intramuscularly, 2 to 3 times a week, to out-patients. Forty to 80 mgs. of Elcitonin was injected intramuscularly, daily to hospitalized patients. Relief of the pain was obtained in 71.4% of all patients (71.4% of out-patients and 71.4% of hospitalized patients) and especially in 88.9% of prostatic carcinoma patients. Hypercalcemia was seen in only one patient of renal cell carcinoma. It is considered that Elcitonin treatment is useful for relief of bony pain in the patients with bone metastases, with or without hypercalcemia.
Tokunaka
S
S
Department of Urology, Asahikawa Medical College.
Fujii
H
H
Okamura
K
K
Hashimoto
H
H
Fujisawa
M
M
Miyata
M
M
Arima
S
S
Yachiku
S
S
D000368:Aged; D000369:Aged, 80 and over; D001859:Bone Neoplasms / Q000503:physiopathology / Q000556:secondary*; D002116:Calcitonin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010148:Intractable Pain / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000503:physiopathology
D002116:Calcitonin; C012755:elcatonin